Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 190,142 | 119,976 | 113,024 | 99,692 | 68,639 |
| Marketable Securities | 866,633 | 498,985 | 501,800 | 439,547 | 497,083 |
| Receivables | N/A | 834 | 1,283 | 2,499 | 985 |
| TOTAL | $1,067,810 | $638,704 | $628,051 | $561,416 | $586,575 |
| Non-Current Assets | |||||
| PPE Net | 65,689 | 68,018 | 68,748 | 75,614 | 77,248 |
| Investments And Advances | 305,361 | 15,376 | 40,534 | 15,468 | 26,871 |
| Other Non-Current Assets | 84,928 | 85,984 | 86,983 | 88,116 | 89,205 |
| TOTAL | $455,978 | $169,378 | $196,265 | $179,198 | $193,324 |
| Total Assets | $1,523,788 | $808,082 | $824,316 | $740,614 | $779,899 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,520 | 11,520 | 10,080 | N/A | N/A |
| Accounts payable and accrued liabilities | 9,470 | 12,967 | 21,507 | 13,796 | 12,561 |
| Accrued Expenses | 39,813 | 40,123 | 42,641 | 32,954 | 31,470 |
| Other current liabilities | 23,467 | 6,015 | 10,559 | 13,737 | 5,885 |
| TOTAL | $102,777 | $88,855 | $102,678 | $77,723 | $65,617 |
| Non-Current Liabilities | |||||
| Long Term Debt | 92,831 | 56,822 | 58,384 | 60,885 | 62,492 |
| Other Non-Current Liabilities | 1,219,630 | 1,058,565 | 1,049,577 | 1,040,807 | 984,905 |
| TOTAL | $1,312,461 | $1,115,387 | $1,107,961 | $1,101,692 | $1,047,397 |
| Total Liabilities | $1,415,238 | $1,204,242 | $1,210,639 | $1,179,415 | $1,113,014 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,660 | 104,854 | 103,005 | 98,054 | 95,998 |
| Common Shares | 117 | 105 | 102 | 94 | 94 |
| Retained earnings | -2,391,199 | -2,247,881 | -2,112,238 | -1,975,342 | -1,845,920 |
| Other shareholders' equity | -1,022 | -539 | -10 | -874 | -1,458 |
| TOTAL | $108,550 | $-396,160 | $-386,323 | $-438,801 | $-333,115 |
| Total Liabilities And Equity | $1,523,788 | $808,082 | $824,316 | $740,614 | $779,899 |